Abingdon Health’s core technology is based on rapid lateral flow immunoassay diagnostics and associated reader systems.
We are also developing the next generation of multiplexed rapid diagnostics technology to meet the market need for simple-to-use, rapid, cost effective, portable system.
Read how our customers use lateral flow assays for rapid nucleic acid detection. https://t.co/NsKWHpbu6N https://t.co/aQ39ReXLmd
17 August 2017
© Abingdon Health 2017